Repligen Corp. (RGEN)
120.77
-4.26
(-3.41%)
USD |
NASDAQ |
Mar 06, 10:55
Repligen Free Cash Flow : 91.69M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Orthofix Medical, Inc. | -1.319M |
| InfuSystem Holdings, Inc. | 23.85M |
| Abbott Laboratories | 7.395B |
| Accuray, Inc. | -10.71M |
| Plus Therapeutics, Inc. | -15.78M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 25.70M |
| Cash from Investing (Quarterly) | -208.74M |
| Cash from Financing (Quarterly) | 0.195M |
| Free Cash Flow Per Share (Quarterly) | 0.307 |
| Free Cash Flow to Equity (Quarterly) | 16.31M |
| Free Cash Flow to Firm (Quarterly) | 21.50M |
| Free Cash Flow Yield | 1.34% |